Vivek Bhalla, MD
Academic Appointments
- Assistant Professor, Medicine - Nephrology
- Member, Child Health Research Institute
Key Documents
Contact Information
-
Clinical Offices
Nephrology Clinic 300 Pasteur Dr MC 5309 A175 Stanford, CA 94305 Tel Work (650) 723-6961 Fax (650) 725-8418
- Academic Offices
Personal Information Email Tel (650) 721-2471Alternate Contact Susan Johnson Manager, Division of Nephrology Email Tel Work 650-498-4809Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Nephrology
- Nephrology (Kidney)
- Diabtetic Kidney Disease
- Hypertension
Honors and Awards
- Carl W. Gottschalk Research Grant, American Society of Nephrology (2010-2012)
- Shaul G. Massry Young InvestigatorÂ’s Award, National Kidney Foundation (2008)
- Teaching Awardee, Halie T. Debas Academy of Medical Educators, UCSF (2007)
- Mentored Clinical Scientist Award, NIH/NIDDK (2005)
- Fellow, American Society of Nephrology (2003)
Professional Education
| Board Certification: | Nephrology, American Board of Internal Medicine (2003) |
| Fellowship: | UCSF-Graduate Medical Education CA (2005) |
| Residency: | Harbor-UCLA Medical Center CA (2001) |
| Medical Education: | University of California San Diego CA (1998) |
| Fellowship: | Univ of California San Francisco, Nephrology (2005) |
Graduate & Fellowship Program Affiliations
Internet Links
Scientific Focus
Current Research Interests
Dr. Bhalla's research interests are in the pathogenesis of diabetic kidney disease and salt-sensitive hypertension. Using molecular and transgenic approaches, the laboratory is interested in elucidating regulators of oxidative and carbonyl stress in glomeruli. We interface these studies with collaborative projects on biomarkers for human diabetic nephropathy.
The laboratory also focuses on molecular mechanisms of insulin and aldosterone-induced sodium transport in the distal nephron.
Publications
- In diabetic nephropathy, high doses of vitamin B decrease glomerular filtration rate and increase risk of the composite outcome of a vascular event or all-cause mortality compared with placebo. Evid Based Med. 2011; (1): 14-5
- Neural precursor cell-expressed developmentally down-regulated protein 4-2 (Nedd4-2) regulation by 14-3-3 protein binding at canonical serum and glucocorticoid kinase 1 (SGK1) phosphorylation sites. J Biol Chem. 2011; (43): 37830-40
- Phosphopeptide screen uncovers novel phosphorylation sites of Nedd4-2 that potentiate its inhibition of the epithelial Na+ channel. J Biol Chem. 2010; (28): 21671-8
- Lead poisoning from an Ayurvedic herbal medicine in a patient with chronic kidney disease. Nat Rev Nephrol. 2009; (5): 297-300
- Melamine nephrotoxicity: an emerging epidemic in an era of globalization. Kidney Int. 2009; (8): 774-9
Help